Dapsone agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced*; D000962:Antimalarials / Q000009:adverse effects*; D003622:Dapsone / Q000009:adverse effects*; D004357:Drug Synergism; D006801:Humans; D008297:Male; D008887:Military Medicine; D011339:Probenecid / Q000494:pharmacology; D014481:United States; D014744:Vietnam
D000962:Antimalarials; D003622:Dapsone; D011339:Probenecid